A Multi-Center Study on the Clinical Advantages of Personalized Total Knee Arthroplasty System
A Multi-Center Prospective Cohort Study on the Clinical Advantages of Personalized Total Knee Arthroplasty System
1 other identifier
observational
80
1 country
1
Brief Summary
The purpose of this study is to evaluate the clinical benefits of personalized total knee arthroplasty (TKA) in comparison with conventional TKA. The study aims to assess surgical outcomes, functional recovery, complication rates, and cost-effectiveness in a multi-center, prospective cohort study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 18, 2025
CompletedStudy Start
First participant enrolled
June 1, 2025
CompletedFirst Posted
Study publicly available on registry
June 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
June 4, 2025
May 1, 2025
2.6 years
March 18, 2025
May 25, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Knee Society Score (KSS)
The Knee Society Score is a standardized assessment tool to evaluate pain, range of motion, and functional ability following total knee arthroplasty. It includes two sub-scores: a clinical knee score and a functional score. Each sub-score ranges from 0 to 100, with higher scores indicating better outcomes.
At baseline, 6 months, and 12 months post-surgery
Secondary Outcomes (7)
Pain Severity - Visual Analog Scale (VAS)
At baseline, 6 months, and 12 months post-surgery.
Pain Severity - Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
At baseline, 6 months, and 12 months post-surgery
Functional Improvement - SF-36 Health Survey
At baseline, 6 months, and 12 months post-surgery.
Functional Improvement - Knee Injury and Osteoarthritis Outcome Score (KOOS)
At baseline, 6 months, and 12 months post-surgery
Functional Improvement - Gait Analysis
At baseline, 6 months, and 12 months post-surgery
- +2 more secondary outcomes
Study Arms (1)
Cohort 1
A total of 80 participants will be enrolled, with 40 receiving personalized total knee arthroplasty and 40 receiving conventional TKA. Participants will be followed for one year post-surgery to assess clinical outcomes.
Eligibility Criteria
This study will recruit adult patients aged 50-80 years who are undergoing total knee arthroplasty for end-stage knee osteoarthritis or related conditions. Participants will be selected from multiple hospital centers to ensure a diverse patient population.
You may qualify if:
- Patients aged 50-80 years.
- Diagnosed with end-stage knee osteoarthritis, post-traumatic arthritis, avascular necrosis, or inflammatory arthritis requiring total knee arthroplasty.
- Willing and able to provide informed consent.
You may not qualify if:
- History of prior knee surgery or knee replacement.
- Severe knee deformity (valgus \>20° or varus \>15°) or instability.
- Severe contracture (\>25° flexion contracture).
- Undergoing total knee revision surgery.
- Rheumatoid arthritis diagnosis.
- BMI \>35.
- Neuromuscular disorders affecting knee stability or gait.
- Pregnancy or lactation.
- Presence of significant comorbidities posing unacceptable risk, including but not limited to metabolic, renal, hepatic, pulmonary, cardiac, hematologic, neurological, endocrine, infectious, or gastrointestinal conditions.
- Active or recent severe infections or malignancy.
- History of drug or alcohol abuse in the past six months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- YujiakuoTHUlead
- Peking University Shougang Hospitalcollaborator
- Beijing Chao Yang Hospitalcollaborator
Study Sites (1)
Beijing Tsinghua Chang Gung Hospital
Beijing, Beijing Municipality, 102218, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prof.
Study Record Dates
First Submitted
March 18, 2025
First Posted
June 4, 2025
Study Start
June 1, 2025
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
June 4, 2025
Record last verified: 2025-05